Work

Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-134272

Authors: Betul Oran, Gheath Alatrash, Amin M. Alousi, Rohtesh S. Mehta, Chitra Hosing, Uday R. Popat, Jin S. Im, Jessica M McCarty, Jennifer D Ramos, Harold N. Keer, Peter F Thall, Richard E. Champlin

Institutions: The University of Texas MD Anderson Cancer Center, Astex Pharmaceuticals

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096368896

FWCI: 0.158

Cites:

Cited by: 2

Related to: 10